期刊文献+

全身^(18)F-FDGPET-CT显像在甲状腺疾病检测的价值 被引量:5

The Value of PET-CT ^(18)F-FDG Imaging in Thyroid Disease Detection
下载PDF
导出
摘要 目的分析全身18F-FDG PET/CT对甲状腺疾病检测的临床诊断价值。方法选取本院2014年2月至2015年4月收治的600例肿瘤患者和健康受试者作为研究对象,采用PET/CT对患者进行全身扫描,通过EBW工作站对扫描数据进行处理得到三个不同轴位的断层图像和融合图像。采用PET/CT影像学方法测定甲状腺疾病的良、恶性判断,并研究标准摄取值(Standardized Uptake Value,SUV)用于诊断甲状腺良、恶性病变的临床价值。甲状腺疾病最终均需采用99m Tc-甲状腺扫描、甲状腺功能5项检查、穿刺或手术及6个月的跟踪随访而进行综合考虑才可确定。结果采用PET/CT影像学方法共查出甲状腺疾病患者52例,检出率为8.7%(52/600),其中第1-5种情况分别查出28例、2例、14例、4例和4例。其中良性病变的SUV值为(2.7±2.1),而恶性病变为(3.1±1.4),但经统计分析,不具有显著性差异(P>0.05)。结论采用全身18F-FDG PET/CT检查方法对甲状腺疾病的诊断具有一定的临床价值,仅采用SUV值对良、恶性病变的诊断效果不佳,需将CT和PET进行结合对良、恶性病变的诊断结果更加可靠。 Objective To analyze the clinical diagnostic value of PET/CT 18F-FDG for thyroid disease detection. Methods Selected in our hospital in 2014 February to April 2015 from 600 cases of tumor patients and healthy subjects as the object of study by PET/CT for patients with whole body scan, by EBW workstation on the scanning data were from three different axial tomographic images and fusion images. By PET/CT imaging method for determination of benign or malignant judgment of thyroid disease, and to study the standard uptake value(standardized uptake value, SUV) for the clinical value of diagnosis of thyroid benign and malignant lesions. Thyroid diseases ultimately need to use 99 m Tcthyroid scanning, thyroid function 5 examination, puncture or surgery and 6 months of follow-up and comprehensive consideration can be determined. Results Results 52 patients with thyroid disease were detected by PET/CT imaging, the detection rate was 8.7%(52/600), and the cases of 1~5 were found in 28 cases, 2 cases, 14 cases, 4 cases and 4 cases.. The 1~4 diagnosis of PET/CT was more benign and the fifth cases were malignant.. The benign lesions of the SUV values(+ 2.7 2.1), and malignant lesions(+ 3.1 1.4), visible lesions from malignant than benign lesions, but the statistics analysis, has no significant difference(P〉0.05). Conclusion Conclusion By whole body 18F-FDG PET/CT method for thyroid disease diagnosis has certain clinical value, only the SUV values poor effect in the diagnosis of benign and malignant lesions, should be combined with the diagnosis of benign and malignant lesions result more reliable CT and pet, when CT results show thyroid local density decreases, and elevated metabolic pet and SUV value higher than 2.5 for malignant lesions and diagnosis with high clinical value.
出处 《中国CT和MRI杂志》 2015年第8期27-29,2,共3页 Chinese Journal of CT and MRI
关键词 18F-FDG PET-CT 甲状腺疾病 诊断价值 18F-FDG PET-CT Thyroid Disease Diagnostic Value
  • 引文网络
  • 相关文献

参考文献10

  • 1DeIbeke D, Coleman R E, Guiberteau M J, et al. Procedure guideline for tumor imaging with 18F-FDG PET/ CT 1.0[J]. Journal of Nuclear Medicine, 2006, 47(5): 885-895.
  • 2Lerman H, Metser U, 6risaru D, et al. Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre-and postmenopausal patients: assessment by PET/CT[J]. Journal of Nuclear Medicine, 2004, 45(2): 266-271.
  • 3蔡胜男,张昌秋,邢忠,韩桂文,徐桂霞.分析甲状腺癌的临床病理及PET-CT的诊断价值[J].中外女性健康,2014,0(04X):18-18. 被引量:4
  • 4Choi J Y, Lee K S, Kim H J, et al. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization[J]. Journal of Nuclear Medicine, 2006, 47(4): 609-615.
  • 5Bogsrud T V, Karantanis D, Nathan M A, et al. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT[J]. Nuclear medicine communications, 2007, 28 (5): 373-381.
  • 6王胜军,汪静,杨卫东,王云雅,王喜青,刘兴安,马晓伟,安晓莉.全身^(18)F-FDG PET-CT在甲状腺疾病检测的价值[J].功能与分子医学影像学(电子版),2013,2(4):15-18. 被引量:1
  • 7Mitchell J C, Grant F, Evenson A R, et al. Preoperative evaluation of thyroid nodules with 18 FDG-PET/CT[J]. Surgery, 2005, 138(6): 1166-1175.
  • 8Yun M, Kim W, Alnafisi N, et al. 18F-FDG PET in characterizing adrenal lesions detected on CY or MRI[J]. Journal of Nuclear Medicine, 2001, 42(12): 1795- 1799.
  • 9Cohade C, Osman M, Pannu H K, et al. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FD6 PET/ CT[J]. Journal of Nuclear Medicine, 2003, 44(2): 170- 176.
  • 10吴江,朱虹,王新刚,桂一,刘伟彦.^(18)F-FDGPET/CT显像在甲状腺病变的应用:与病理对比分析[J].中国临床医学影像杂志,2013,24(4):242-246. 被引量:7

二级参考文献30

  • 1刘复生,吕宁.甲状腺癌的病理特点与预后关系[J].中华肿瘤杂志,1993,15(5):381-384. 被引量:9
  • 2Mitchell JC, Grant F, Evenson AR, et al. Preoperative evaluation of thyroid nodules with SFDG-PET/CT [J]. Surgery, 2005, 138(6): 1166-1175.
  • 3Chen W, Parsons M, Torigian DA, et al. Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging[J]. Nuel Med Commun, 2009, 30(3): 240-244.
  • 4Bae JS, Chae BJ, Park WC, et al. Incidental thyroid lesions de- tected by FDG-PET/CT: prevalence and risk of thyroid cancer[J]. World J Surg Oncol, 2009, 7: 63.
  • 5Nishimori H, Tabah R, Hickeson M, et al. Incidental thyroid "PETomas": clinical significance and novel description of the self-resolving variant of focal FDG-PET thyroid uptake[J]. Can J Surg, 2011, 54(2): 83-88.
  • 6Pagano L, Sama MT, Morani F, et al. Thyroid incidentaloma i- dentified by 8F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance[J]. Clin Endocrinol, 2011, 75(4): 528-534.
  • 7Choi JY, Lee KS, Kim HJ, et al. Focal thyroid lesions inciden- tally identified by integrated ISF-FDG PET/CT: clinical signifi- cance and improved characterization[J]. J Nucl Med, 2006, 47(4): 609-615.
  • 8Chu QD, Connor MS, Lilien DL, et al. Positron emission tomog- raphy(PET) positive thyroid incidentaloma: the risk of malignancy observed in a tertiary referral center [J]. Am Surg, 2006, 72(3): 272-275.
  • 9Wong C, Lin M, Chicco A, et al. The clinical significance and management of incidental focal FDG uptake in the thyroid gland on positron emission tomography/computed tomography(PET/CT) in patients with non-thyroidal malignancy[J]. Acta Radiol, 2011, 52(8): 899-904.
  • 10Bogsrud TV, Karantanis D, Nathan MA, et al. The value of quantifying lSF-FDG uptake in thyroid nodules found incidental- ly on whole-body PET-CT [J]. Nucl Med Commun, 2007, 28(5): 373-381.

共引文献9

同被引文献83

  • 1詹维伟,徐上妍.甲状腺结节超声检查新进展[J].中华医学超声杂志(电子版),2013,10(2):88-93. 被引量:73
  • 2Benga 6. Water Channel Proteins (Later Called Aquaporins) and Relatives: Past, Present, and Future[J]. IVBMB Life. 2009 ;61(2):112-33.
  • 3White NS, McDonald CR, Farid N, et al. Improved conspicuity and delineation of high-grade primary and metastatic brain tumors using "restriction spectrum imaging" :Quantitative comparison with high b-value DWI and ADC [J] . Am J Neuroradiol. 34(5): 958-977.
  • 4Takahara T, Kwee TC. Ultra- high-b-value diffusion- weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation[J]. Eur Radiol 2011;21(1): 188-196.
  • 5Choi SH, Paeng JC, Sohn CH, et al. Correlation of 18F-FOG uptake with apparent diffusion coefficient ratio measured on standard and high b value diffusion MRI in head and Neck Cancer[J]. J Nucl Ned. 2011;52(7):1056-1062.
  • 6Gustav K. yon S, Felix PK, Philipp K, et al. Clinical positron emission tomography/.magnetic resonance imaging applications[Jl. Seminar in Nucl Med. 2013;43(1):3-13.
  • 7Niu DF, Kondo T, al. Differential aquaporins and Nakazawa T, et expression of its diagnosticutility in thyroid cancer[J]. PLoS ONE 2012;7(7): e40770.
  • 8Verkman AS, Hara-Chikuma M ,Papadopoulos MC. Aquaporins- new players in cancer biology [J]. Mol Med (Berl), 2008, 86 (5) : 523-529.
  • 9Gu J, Khong PL, Wang SL, et al. Quantitaive assement of diffusion-weighted MR imaging in patients with primary rectal cancer: correlation with FDG- PET/CT[J]. Mol Imaging 2011; 13(5): 1020-1028. Biol.
  • 10Varoquaux A, Rager O, Lovblad KO, et al, Functional imaging of head and neck squamous ceil carcinoma with diffusion- weighted RRI and FB6 PET/ CY:quantitative analysis of ADC and SUV[J]. Eur J Nucl Med Mol Imaging. 2013;40(6):842-852.

引证文献5

二级引证文献35

;
使用帮助 返回顶部